Overview

Basic information

Litigation

Active legal matters

Material Events

8-K disclosures

SEC Filings

Key regulatory docs

Insider Transactions

Ownership changes

Overview

Basic information

Litigation

Active legal matters

Material Events

8-K disclosures

SEC Filings

Key regulatory docs

Insider Transactions

Ownership changes

Securities Class Action

Securities fraud litigation history and active cases

In Litigation

1

Settlement

0

Closed

0

Total Settlement

$0

Telix Pharmaceuticals Ltd (TLX) Class Action Lawsuit (November 2025)

In Litigation

1:25cv2299 • November 10, 2025

Class Period Start

November 14, 2024

Class Period End

August 28, 2025

PSLRA Deadline

January 9, 2026

Case Allegations

10b5

Statutes of Repose

Nov 14, 2027

Country

United States

Court

Federal Court

Docket History

Jun 26, 2026

Motion to Dismiss

After reviewing the complaint(s) filed by plaintiffs, defendants have filed a motion requesting that the court dismiss some or all of the plaintiffs' claims. In a motion to dismiss, defendants might challenge the validity of plaintiffs' claims or adequacy of plaintiffs' pleadings. Once a motion to dismiss is filed, the judge will make a decision on whether part or all of the case should be dismissed or the case can proceed as alleged.

Apr 27, 2026

First Amended Complaint

A new complaint has been filed on behalf of certain investors in Telix Pharmaceuticals Ltd. Amended complaints may contain additional facts, parties, allegations, a change in the class definition, etc.

Feb 24, 2026

Appointment of Lead Plaintiff

The court has appointed a lead plaintiff to represent the interests of investors in the lawsuit. The lead plaintiff works with the attorneys handling the case, helps oversee the litigation, and represents the interests of the proposed class.

Nov 10, 2025

First Filed Complaint

A securities fraud class action complaint has been filed on behalf of certain investors in Telix Pharmaceuticals Ltd.

TOP